LLY FY 2016 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

FY 2016 Earnings

Reported February 21, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2016	Prior Q	FY 2015	QoQ Change	YoY Change
Revenue	$21.2B	—	$20.0B	—	6.3%
Op. Income	$3.9B	—	$3.6B	—	7.8%
Gross Margin	73.1%	—	74.8%	—	-1.7pp
Net Margin	12.9%	—	12.1%	—	0.8pp
EPS (Diluted)	$2.49	—	$2.18	—	14.2%
Free Cash Flow	$3.8B	—	$1.3B	—	180.9%

Revenue Flow

Item	Amount
REVENUE	$21.2B
Cost of Revenue	$5.7B
GROSS PROFIT	$15.5B
R&D Expenses	$5.3B
Selling & Marketing	$0
General & Administrative	$6.3B
SG&A Expenses	$6.3B
Other Expenses	$0
Operating Expenses	$11.6B
Cost & Expenses	$17.4B
OPERATING INCOME	$3.9B
Interest Income	$109M
Interest Expense	$185M
Other Income/Expenses	-$497M
INCOME BEFORE TAX	$3.4B
Income Tax Expense	$636M
Net Income from Continuing Ops	$2.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$2.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.7B
D&A	$1.5B
EBIT	$3.6B
EBITDA	$5.1B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$21.2B
Cost of Revenue	$5.7B
GROSS PROFIT	$15.5B
R&D Expenses	$5.3B
Selling & Marketing	$0
General & Administrative	$6.3B
SG&A Expenses	$6.3B
Other Expenses	$0
Operating Expenses	$11.6B
Cost & Expenses	$17.4B
OPERATING INCOME	$3.9B
Interest Income	$109M
Interest Expense	$185M
Other Income/Expenses	-$497M
INCOME BEFORE TAX	$3.4B
Income Tax Expense	$636M
Net Income from Continuing Ops	$2.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$2.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.7B
D&A	$1.5B
EBIT	$3.6B
EBITDA	$5.1B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$2.7B
Depreciation & Amortization	$1.5B
Stock-Based Compensation	$255M
Deferred Income Tax	$440M
Other Non-Cash Items	$406M
Change in Working Capital	-$484M
OPERATING CASH FLOW	$4.9B
Capital Expenditure	-$1.1B
Acquisitions (Net)	-$45M
Purchases of Investments	-$5.7B
Sales/Maturities of Investments	$3.7B
Other Investing Activities	-$57M
NET CASH FROM INVESTING	-$3.1B
Net Debt Issuance	$2.5B
Common Stock Repurchased	-$600M
Common Dividends Paid	-$2.2B
Other Financing Activities	-$301M
NET CASH FROM FINANCING	-$560M
FREE CASH FLOW	$3.8B
Net Change in Cash	$916M

Balance Sheet

Item	Amount
Cash & Equivalents	$4.6B
Short-Term Investments	$1.5B
Net Receivables	$4.8B
Inventory	$3.6B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$15.1B
PP&E (Net)	$8.3B
Goodwill	$4.0B
Intangible Assets	$4.4B
Long-Term Investments	$5.2B
Tax Assets	$0
Other Non-Current Assets	$1.9B
TOTAL NON-CURRENT ASSETS	$23.7B
TOTAL ASSETS	$38.8B
Account Payables	$1.3B
Short-Term Debt	$1.9B
Deferred Revenue	$0
Other Current Liabilities	$6.6B
TOTAL CURRENT LIABILITIES	$11.0B
Long-Term Debt	$8.4B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$5.4B
TOTAL NON-CURRENT LIABILITIES	$13.7B
TOTAL LIABILITIES	$24.7B
Common Stock	$689M
Additional Paid-In Capital	$5.6B
Retained Earnings	$16.0B
Treasury Stock	-$81M
Accum. Other Comp. Income	-$8.3B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$14.0B
Minority Interest	$73M
TOTAL EQUITY	$14.1B
TOTAL LIABILITIES & EQUITY	$38.8B
Total Debt	$10.3B
Net Debt	$5.7B